Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2006-01-11
2010-10-12
Layno, Carl H (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S002000
Reexamination Certificate
active
07813805
ABSTRACT:
In one embodiment, an implantable stimulation apparatus includes a vagal nerve stimulator configured to generate electrical pulses below a cardiac threshold of a heart, and an electrode coupled to the vagal nerve stimulator which is configured to transmit the electrical pulses below the cardiac threshold, to a vagal nerve so as to inhibit injury resulting from an ischemia and/or reduce injury resulting from an ischemia. In another embodiment, an implantable stimulation apparatus includes a vagal nerve stimulator configured to generate electrical pulses below a cardiac threshold, and includes an electrode, which is coupled to the vagal nerve stimulator and configured transmit electrical pulses to a vagal nerve so as to reduce a defibrillation threshold of the heart.
REFERENCES:
patent: 3774618 (1973-11-01), Avery
patent: 4860769 (1989-08-01), Fogarty et al.
patent: 4934368 (1990-06-01), Lynch
patent: 5170802 (1992-12-01), Mehra
patent: 5224491 (1993-07-01), Mehra
patent: 5231988 (1993-08-01), Wernicke et al.
patent: 5251634 (1993-10-01), Weinberg
patent: 5320643 (1994-06-01), Roline et al.
patent: 5330507 (1994-07-01), Schwartz
patent: 5387233 (1995-02-01), Alferness et al.
patent: 5411546 (1995-05-01), Bowald et al.
patent: 5441521 (1995-08-01), Hedberg
patent: 5476498 (1995-12-01), Ayers
patent: 5578061 (1996-11-01), Stroetmann et al.
patent: 5658318 (1997-08-01), Stroetmann et al.
patent: 5690681 (1997-11-01), Geddes
patent: 5916239 (1999-06-01), Geddes
patent: 5978705 (1999-11-01), KenKnight
patent: 6129750 (2000-10-01), Tockman et al.
patent: 6134470 (2000-10-01), Hartlaub
patent: 6157862 (2000-12-01), Brownlee
patent: 6292695 (2001-09-01), Webster, Jr. et al.
patent: 6341236 (2002-01-01), Osorio et al.
patent: 6349233 (2002-02-01), Adams
patent: 6473644 (2002-10-01), Terry et al.
patent: 6564096 (2003-05-01), Mest
patent: 6587727 (2003-07-01), Osorio
patent: 6610713 (2003-08-01), Tracey
patent: 6615081 (2003-09-01), Boveja
patent: 6628987 (2003-09-01), Hill
patent: 6671556 (2003-12-01), Osorio
patent: 6972016 (2005-12-01), Hill et al.
patent: 7031777 (2006-04-01), Hine et al.
patent: 7072720 (2006-07-01), Puskas
patent: 7321793 (2008-01-01), Ben Ezra
patent: 2002/0120304 (2002-08-01), Mest
patent: 2002/0123771 (2002-09-01), Ideker et al.
patent: 2003/0078623 (2003-04-01), Weinberg et al.
patent: 2003/0181951 (2003-09-01), Cates
patent: 2003/0229380 (2003-12-01), Adams et al.
patent: 2004/0019364 (2004-01-01), Kieval
patent: 2004/0038857 (2004-02-01), Tracey
patent: 2004/0172075 (2004-09-01), Shafer
patent: 2005/0065553 (2005-03-01), Ben Ezra
patent: 2005/0143787 (2005-06-01), Boveja
patent: 2005/0149131 (2005-07-01), Libbus
patent: 2006/0173493 (2006-08-01), Armstrong et al.
patent: 2006/0178703 (2006-08-01), Huston et al.
patent: 0566652 (1994-06-01), None
patent: 0566652 (1997-11-01), None
patent: 1304135 (2003-04-01), None
Borovikova et al. “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin.” Nature. vol. 405. May 2000.
Borovikova et al. “Role of the Efferent Vagus Nerve Signaling in the Regulation of the Innate Immune Response to LPS.” Shock, vol. 13, 2000.
Blum et al. “Role of Cytokines in Heart Failure.” American Heart Journal. Feb. 1998.
Non-Final Office Action mailed May 18, 2007: Related U.S. Appl. No. 11/120,345.
Final Office Action mailed Nov. 28, 2007: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed May 9, 2008: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed May 28, 2008: Related U.S. Appl. No. 11/283,229.
Non-Final Office Action mailed Jan. 29, 2009: Related U.S. Appl. No. 11/330,884.
Non-Final Office Action mailed Oct. 23, 2008: Related U.S. Appl. No. 11/539,326.
Final Office Action mailed Apr. 7, 2009: Related U.S. Appl. No. 11/539,326.
Final Office Action mailed Dec. 16, 2008: Related U.S. Appl. No. 11/120,345.
Non-Final Office Action mailed Mar. 6, 2009: Related U.S. Appl. No. 11/120,345.
Final Office Action mailed Mar. 18, 2009: Related U.S. Appl. No. 11/283,229.
Non-Final Office Action mailed Sep. 19, 2008: Related U.S. Appl. No. 11/330,884.
Non-Final Office Action mailed Jun. 29, 2009: Related U.S. Appl. No. 11/330,884.
Final Office Action mailed Nov. 25, 2009: Related U.S. Appl. No. 11/330,884.
Final Office Action mailed Feb. 22, 2010: Related U.S. Appl. No. 11/330,884.
Non-Final Office Action mailed May 28, 2008: Related U.S. Appl. No. 11/283,229.
Final Office Action mailed Mar. 18, 2009: Related U.S. Appl. No. 11/283,229.
Final Office Action mailed Feb. 25, 2010: Related U.S. Appl. No. 11/283,229.
Behringer Luther G
Layno Carl H
Mitchell Steven M.
Pacesetter Inc.
Takeuchi Theresa A.
LandOfFree
Subcardiac threshold vagal nerve stimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Subcardiac threshold vagal nerve stimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Subcardiac threshold vagal nerve stimulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4179810